← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Health Network
Toronto, ON
$110,138,745
Total funding
87
Grants
Funding over time
peak $9.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$90,593,849 · 60
DOD$19,544,896 · 27
By mechanism
R01$32,547,283 · 28
U01$28,781,728 · 12
—$19,544,896 · 27
UM1$14,859,350 · 1
N01$7,366,902 · 4
R21$3,075,853 · 8
Investigators at University Health Network
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
North American Star Consortium$5,963,609
UM1 · FY2020 · CA
CELL POLARITY REGULATION DURING BREAST CANCER PROGRESSION: NOVEL PATHWAYS FOR DIAGNOSIS AND TREATMENT$3,859,357
· FY2008 · Department of Defense
North American Star Consortium$2,106,066
UM1 · FY2023 · CA
North American Star Consortium$1,720,919
UM1 · FY2025 · CA
THE SURVEILLANCE RECEPTOR TRPM2: A NOVEL THERAPEUTIC TARGET FOR RETT SYNDROME?$1,526,748
· FY2020 · Defense Health Agency
COMPREHENSIVE EVALUATION OF IMMUNE FUNCTION IN PATIENTS RECEIVING MULTIMODAL THERAPY FOR HIGH-RISK NEUROBLASTOMA$1,419,453
· FY2022 · Department of the Army
INHIBITING INTERACTION OF PNUTS WITH THE MYC FAMILY OF ONCOPROTEINS TO EFFECTIVELY TARGET BREAST CANCER$1,232,483
· FY2021 · Defense Health Agency
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$1,198,933
U01 · FY2016 · NS
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$1,152,717
U01 · FY2015 · NS
DEFINING THE ROLE OF THE RAS PATHWAY IN BRAIN ARTERIOVENOUS MALFORMATIONS$1,129,426
· FY2018 · Department of the Army
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$1,116,421
N01 · FY2015 · CA
TARGETING THE MEVALONATE PATHWAY AND ITS RESTORATIVE FEEDBACK LOOP IN BREAST CANCER$1,093,280
· FY2016 · Department of the Army
Princess Margaret Phase I Consorium (PMP1C)$1,003,004
UM1 · FY2016 · CA
TASK A88: Ferret Model for Testing of Universal Influenza Vaccine Candidates$986,910
N01 · FY2015 · AI
Generation of functional beta cells from stem and progenitor cells$949,125
U01 · FY2010 · DK
Generation of functional beta cells from stem and progenitor cells$949,124
U01 · FY2011 · DK
Generation of functional beta cells from stem and progenitor cells$943,094
U01 · FY2012 · DK
Princess Margaret Phase I Consorium (PMP1C)$932,981
UM1 · FY2018 · CA
Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing$926,095
R01 · FY2022 · AG
North American Star Consortium$920,429
UM1 · FY2024 · CA